PRESS BOX
MORE IR NEWS
Release according to art. 93 section 2 BörseG
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
Release of capital market information
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
 
ANNOUNCEMENT OF 10.06.2017 05:00 PM
Meldung drucken Artikel weiterleiten
pta20171006034
Announcement according to article 2 section 3 of the Regulation (EC) 2016/1052
Pressefach Pressefach

Nexus AG: Release of capital market information

50. Interim Reporting

Donaueschingen (pta034/06.10.2017/17:00) - In the time period from October 02, 2017 until and including October 06, 2017, no shares were bought back within the framework of the share buy-back program of NEXUS AG, whose start was disclosed by NEXUS AG on October 25, 2016.

The transactions in a detailed form are published on the website of NEXUS AG (www.nexus-ag.de - Investor Relations - Stock Buyback)

The total volume of shares, which have been bought back within the framework of the share buy-back amounts to 18,755 shares.

The purchase of the shares of NEXUS AG is carried out by a credit institution that has been commissioned by NEXUS AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (Xetra).

Donaueschingen, 06.10.2017
NEXUS AG
The Managing Board

(end)

emitter: Nexus AG
Irmastraße 1
78166 Donaueschingen
Germany
contact person: Dr. Patrick Stein
phone: +49 771 22960-201
e-mail:
website: www.nexus-ag.de
ISIN(s): DE0005220909 (share)
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin
Nexus AG